Preventive health care, 2001 update: Screening mammography among women aged 40-49 years at average risk of breast cancer

CMAJ. Canadian Medical Association Journal

Volumn 164, Issue 4, 2001, Pages 469-476

  Ringas, J ^a   Feightner, J W ^a   Elford, R W ^a   Labrecque, R W ^a   McLeod, R ^a   Moutquin, J M ^a   Patterson, C ^a   Wang, E E L ^a   Wathen, N ^a   Pauley, T ^a  

^a PARKWOOD HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANADA; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DATA BASE; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MEDICAL INFORMATION; NON INVASIVE MEASUREMENT; PEER REVIEW; PERIODIC MEDICAL EXAMINATION; PREVENTIVE MEDICINE; PUBLICATION; QUALITY OF LIFE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TUMOR BIOPSY;

EID: 0035916348     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. The National Study of Breast Cancer Screening Protocol for a Canadian randomized controlled trial of screening for breast cancer in women
2. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years
3. Screening for breast cancer
4. The Gothenburg Breast Screening Trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization
5. Reduced breast cancer mortality in women under age 50: Updated results from the Malmo Mammographic Screening Program
6. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials
7. Is screening for breast cancer with mammography justifiable?
8. AACR comments on mammography screening for women age 40 to 49
9. National Institutes of Health Consensus Development Conference statement: Breast cancer screening for women ages 40-49, January 21-23, 1997
10. American Cancer Society guidelines for the early detection of breast cancer: Update 1997
11. National Cancer Advisory Board issues mammography screening recommendations. 1997
12. An assessment of clinically useful measures of the consequences of treatment
13. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination
14. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations
15. Ten- to fourteen-year effect of screening on breast cancer mortality
16. Evidence on screening for breast cancer from a randomized trial
17. Periodic screening for breast cancer: The HIP Randomized Controlled Trial. Health Insurance Plan
18. Breast cancer screening with mammography: A population-based, randomized trial with mammography as the only screening mode
19. Mammographic screening and mortality from breast cancer: The Malmo Mammographic Screening Trail
20. Screening for breast cancer: The Swedish trial
21. Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county
22. The Swedish two county trial of mammographic screening for breast cancer: Recent results and calculation of benefit
23. Update of the Swedish two-county program of mammographic screening for breast cancer
24. Recent results from the Swedish two-county trial: The effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening
25. Breast screening, prognostic factors and survival: Results from the Swedish two county study
26. The Edinburgh randomised trial of screening for breast cancer: Description of method
27. The Edinburgh randomised trial of breast cancer screening: Results after 10 years of follow-up
28. 14 Years of follow-up from the Edinburgh randomised trial of breast-cancer screening
29. Randomisation by cluster and the problem of social class bias
30. Impediments to recruitment in the Canadian National Breast Screening Study: Response and resolution
31. The Canadian National Breast Screening Study. An appraisal and implications for early detection policy
32. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada
33. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study
34. Randomization in the Canadian National Breast Screening Study: A review for evidence of subversion
35. Using an alternative data source to examine randomization in the Canadian National Breast Screening Study
36. A different view on what is known about breast screening and the Canadian National Breast Screening Study
37. The Canadian National Breast Screening Study: Update on breast cancer mortality
38. Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey
39. Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons
40. The Stockholm Breast Cancer Screening Trial: 5-year results and stage at discovery
41. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years
42. Meta-anaiysis in clinical research
43. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials
44. Efficacy of screening mammography. A meta-analysis
45. Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis
46. Breast-cancer screening with mammography in women aged 40-49 years
47. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit
48. The quality and interpretation of mammographic screening trials for women ages 40-49
49. Assessment of nationwide cancer-screening programmes
50. Screening mammography re-evaluated
51. Screening mammography re-evaluated
52. Screening mammography re-evaluated
53. Screening mammography re-evaluated
54. Screening mammography re-evaluated
55. Screening mammography re-evaluated
56. Screening mammography re-evaluated
57. Radiation risk from screening mammography of women aged 40-49 years
58. Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers
59. Factors influencing cosmetic results after conservation therapy for breast cancer
60. Ten-year risk of false positive screening mammograms and clinical breast examinations
61. Psychological and behavioral implications of abnormal mammograms
62. Psychological side effects of breast cancer screening
63. How distressing is attendance for routine breast screening?
64. Breast cancer screening among women in their forties: An overview of the issues
65. False positive rate of screening mammography
66. Psychological distress associated with organized breast cancer screening
67. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England
68. The psychological effects of breast screening in terms of patients' perceived health anxieties
69. The short-term psychological impact of organized breast screening
70. Psychological consequences of screening mammography
71. Assessment of the psychological impact of a breast screening programme
72. Psychiatric morbidity associated with screening for breast cancer
73. Variation of benefits and harms of breast cancer screening with age
74. British trial aims to settle mammography questions
75. UICC meeting on breast-cancer screening in pre-menopausal women in developed countries